VALENSIN, PIER EGISTO
VALENSIN, PIER EGISTO
Analysis of the HIV-1 nef gene in five intravenous drug users with long-term nonprogressive HIV-1 infection in Italy.
2000-01-01 Catucci, M; Venturi, G; Romano, Laura; Valensin, PIER EGISTO; Zazzi, Maurizio
Antigenicity and immunogenicity of the V3 domain of HIV-1 gp120 expressed on the surface of Streptococcus gordonii. AIDS Res Hum Retroviruses
1999-01-01 Oggioni, M. R.; Medaglini, D.; Romano, L.; Peruzzi, F.; Maggi, T.; Lozzi, L.; Bracci, L.; Zazzi, M.; Manca, F.; Valensin, P. E.; Pozzi, G.
Antipeptide monoclonal antibodies inhibit the binding of rabies virus glycoprotein and alpha-bungarotoxin to the nicotinic acetylcholine receptor
1988-01-01 Bracci, L.; Antoni, G.; Cusi, M. G.; Lozzi, L.; Niccolai, N.; Petreni, S.; Rustici, M.; Santucci, A.; Soldani, P.; Valensin, P. E.
Antipeptide monoclonal antibodies inhibit the binding of rabiesvirus glycoprotein and alpha-bungarotoxin to the nicotinic acetylcholine receptor
1988-01-01 Bracci, Luisa; Antoni, G.; Cusi, MARIA GRAZIA; Lozzi, Luisa; Niccolai, Neri; Petreni, S.; Rustici, M.; Santucci, Annalisa; Soldani, Patrizia; Valensin, PIER EGISTO; Neri, Paolo
Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples
2000-01-01 Venturi, G.; Catucci, M.; Romano, L.; Corsi, P.; Leoncini, F.; Valensin, P. E.; Zazzi, M.
Antiretroviral therapy with protease inhibitors in human immunodeficiency virus type 1- and human herpesvirus 8 coinfected patients
1999-01-01 DE MILITO, A.; Catucci, M.; Romano, L.; Venturi, G.; Incandela, L.; Valensin, P. E.; Zazzi, M.
Binding properties of monoclonal antibodies to rabies virus
1991-01-01 Cusi, M. G.; Valensin, P. E.; Tollis, M.; Bracci, L.; Petreni, S.; Soldani, P.
Biotechnology for virus vaccine design, production, and control
1989-01-01 Valensin, PIER EGISTO; BIANCHI BANDINELLI, MARIA LETIZIA; Cusi, MARIA GRAZIA; Rossolini, GIAN MARIA; Zazzi, Maurizio
CD4+/CD45RA+ “naive” T cells and immunological response to influenza virus vaccine in B-cell chromnic lymphocitic leukemia patients
1998-01-01 Marotta, G.; Bucalossi, A.; Galieni, P.; Bigazzi, C.; Nuti, S.; Valenzin, P. E.; Bocchia, M.; Lauria, F.
Characterization of immunoreactive octapeptides of human-cytomegalovirus gp58
1993-01-01 Bonci, A.; Bracci, Luisa; Caudai, C.; Lozzi, Luisa; Moschettini, D.; Niccolai, Neri; Scarselli, M.; Valensin, PIER EGISTO; Neri, P.
Clinical evaluation of an in-house reverse transcription-competitive PCR for quantitation of human immunodeficiency virus type 1 plasma RNA.
1999-01-01 Zazzi, Maurizio; Romano, Laura; Catucci, M.; Venturi, G.; DE MILITO, A.; Valensin, PIER EGISTO
Comparative evaluation of three computerized algorithms for prediction of antiretroviral susceptibility from human immunodeficiency virus type 1 genotype
2004-01-01 Zazzi, M.; Romano, L.; Venturi, G.; Shafer, R.; Reid, C.; DAL BELLO, F.; Parolin, C.; Palu', G.; Valensin, P. E.
Comparison of M-MLV reverse transcriptase and Tth polymerase activity in RT-PCR of samples with low virus burden
1994-01-01 Cusi, M. G.; Valassina, M.; Valensin, P. E.
Concordance between polymerase chain reaction and antibody detection in the diagnosis of human immunodeficiency virus type 1 infection.
1995-01-01 Romano, Laura; Catucci, M; DE MILITO, A; Venturi, G; Zazzi, Maurizio; Almi, P; Gonnelli, A; Rubino, M; Valensin, PIER EGISTO
Detection of genotypically drug-resistant HIV-1 variants and non-B subtypes in recently infected antiretroviral-naive adults in Italy.
2000-01-01 Romano, Laura; Venturi, G.; Ferruzzi, R.; Riccio, MARIA LETIZIA; Corsi, P.; Leoncini, F.; Vinattieri, A.; Incandela, L.; Valensin, PIER EGISTO; Zazzi, Maurizio
Development and significance of resistance to protease inhibitors in HIV-1-infected adults under triple-drug therapy in clinical practice.
2002-01-01 Romano, Laura; Venturi, G; Giomi, S; Pippi, L; Valensin, PIER EGISTO; Zazzi, Maurizio
Development and significance of the HIV-1 reverse transcriptase M184V mutation during combination therapy with lamivudine, zidovudine and protease inhibitors
1999-01-01 Catucci, M.; Venturi, G.; Romano, L.; Riccio, M. L.; DE MILITO, A.; Valensin, P. E.; Zazzi, M.
Divergent distribution of HIV-1 drug-resistant variants on and off antiretroviral therapy
2002-01-01 Venturi, G.; Romano, Laura; Carli, T.; Corsi, P.; Pippi, L.; Valensin, PIER EGISTO; Zazzi, Maurizio
Evaluation of cell-free and cell-associated peripheral blood HIV-1 RNA response to antiretroviral therapy
1999-01-01 Romano, Laura; Venturi, G; Catucci, M; DE MILITO, A; Valensin, PIER EGISTO; Zazzi, Maurizio
Evaluation of the presence of 2-LTR HIV-1 unintegrated DNA as a simple molecular predictor of disease progression.
1997-01-01 Zazzi, Maurizio; Romano, Laura; Catucci, M.; Venturi, G.; DE MILITO, A.; Almi, P.; Gonnelli, A.; Rubino, M.; Occhini, U.; Valensin, PIER EGISTO
| Titolo | Data di pubblicazione | Autore(i) | File | Abstract |
|---|---|---|---|---|
| Analysis of the HIV-1 nef gene in five intravenous drug users with long-term nonprogressive HIV-1 infection in Italy. | 1-gen-2000 | Catucci, M; Venturi, G; Romano, Laura; Valensin, PIER EGISTO; Zazzi, Maurizio | - | |
| Antigenicity and immunogenicity of the V3 domain of HIV-1 gp120 expressed on the surface of Streptococcus gordonii. AIDS Res Hum Retroviruses | 1-gen-1999 | Oggioni, M. R.; Medaglini, D.; Romano, L.; Peruzzi, F.; Maggi, T.; Lozzi, L.; Bracci, L.; Zazzi, M.; Manca, F.; Valensin, P. E.; Pozzi, G. | - | |
| Antipeptide monoclonal antibodies inhibit the binding of rabies virus glycoprotein and alpha-bungarotoxin to the nicotinic acetylcholine receptor | 1-gen-1988 | Bracci, L.; Antoni, G.; Cusi, M. G.; Lozzi, L.; Niccolai, N.; Petreni, S.; Rustici, M.; Santucci, A.; Soldani, P.; Valensin, P. E. | - | |
| Antipeptide monoclonal antibodies inhibit the binding of rabiesvirus glycoprotein and alpha-bungarotoxin to the nicotinic acetylcholine receptor | 1-gen-1988 | Bracci, Luisa; Antoni, G.; Cusi, MARIA GRAZIA; Lozzi, Luisa; Niccolai, Neri; Petreni, S.; Rustici, M.; Santucci, Annalisa; Soldani, Patrizia; Valensin, PIER EGISTO; Neri, Paolo | - | |
| Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples | 1-gen-2000 | Venturi, G.; Catucci, M.; Romano, L.; Corsi, P.; Leoncini, F.; Valensin, P. E.; Zazzi, M. | - | |
| Antiretroviral therapy with protease inhibitors in human immunodeficiency virus type 1- and human herpesvirus 8 coinfected patients | 1-gen-1999 | DE MILITO, A.; Catucci, M.; Romano, L.; Venturi, G.; Incandela, L.; Valensin, P. E.; Zazzi, M. | - | |
| Binding properties of monoclonal antibodies to rabies virus | 1-gen-1991 | Cusi, M. G.; Valensin, P. E.; Tollis, M.; Bracci, L.; Petreni, S.; Soldani, P. | - | |
| Biotechnology for virus vaccine design, production, and control | 1-gen-1989 | Valensin, PIER EGISTO; BIANCHI BANDINELLI, MARIA LETIZIA; Cusi, MARIA GRAZIA; Rossolini, GIAN MARIA; Zazzi, Maurizio | - | |
| CD4+/CD45RA+ “naive” T cells and immunological response to influenza virus vaccine in B-cell chromnic lymphocitic leukemia patients | 1-gen-1998 | Marotta, G.; Bucalossi, A.; Galieni, P.; Bigazzi, C.; Nuti, S.; Valenzin, P. E.; Bocchia, M.; Lauria, F. | - | |
| Characterization of immunoreactive octapeptides of human-cytomegalovirus gp58 | 1-gen-1993 | Bonci, A.; Bracci, Luisa; Caudai, C.; Lozzi, Luisa; Moschettini, D.; Niccolai, Neri; Scarselli, M.; Valensin, PIER EGISTO; Neri, P. | - | |
| Clinical evaluation of an in-house reverse transcription-competitive PCR for quantitation of human immunodeficiency virus type 1 plasma RNA. | 1-gen-1999 | Zazzi, Maurizio; Romano, Laura; Catucci, M.; Venturi, G.; DE MILITO, A.; Valensin, PIER EGISTO | - | |
| Comparative evaluation of three computerized algorithms for prediction of antiretroviral susceptibility from human immunodeficiency virus type 1 genotype | 1-gen-2004 | Zazzi, M.; Romano, L.; Venturi, G.; Shafer, R.; Reid, C.; DAL BELLO, F.; Parolin, C.; Palu', G.; Valensin, P. E. | - | |
| Comparison of M-MLV reverse transcriptase and Tth polymerase activity in RT-PCR of samples with low virus burden | 1-gen-1994 | Cusi, M. G.; Valassina, M.; Valensin, P. E. | - | |
| Concordance between polymerase chain reaction and antibody detection in the diagnosis of human immunodeficiency virus type 1 infection. | 1-gen-1995 | Romano, Laura; Catucci, M; DE MILITO, A; Venturi, G; Zazzi, Maurizio; Almi, P; Gonnelli, A; Rubino, M; Valensin, PIER EGISTO | - | |
| Detection of genotypically drug-resistant HIV-1 variants and non-B subtypes in recently infected antiretroviral-naive adults in Italy. | 1-gen-2000 | Romano, Laura; Venturi, G.; Ferruzzi, R.; Riccio, MARIA LETIZIA; Corsi, P.; Leoncini, F.; Vinattieri, A.; Incandela, L.; Valensin, PIER EGISTO; Zazzi, Maurizio | - | |
| Development and significance of resistance to protease inhibitors in HIV-1-infected adults under triple-drug therapy in clinical practice. | 1-gen-2002 | Romano, Laura; Venturi, G; Giomi, S; Pippi, L; Valensin, PIER EGISTO; Zazzi, Maurizio | - | |
| Development and significance of the HIV-1 reverse transcriptase M184V mutation during combination therapy with lamivudine, zidovudine and protease inhibitors | 1-gen-1999 | Catucci, M.; Venturi, G.; Romano, L.; Riccio, M. L.; DE MILITO, A.; Valensin, P. E.; Zazzi, M. | - | |
| Divergent distribution of HIV-1 drug-resistant variants on and off antiretroviral therapy | 1-gen-2002 | Venturi, G.; Romano, Laura; Carli, T.; Corsi, P.; Pippi, L.; Valensin, PIER EGISTO; Zazzi, Maurizio | - | |
| Evaluation of cell-free and cell-associated peripheral blood HIV-1 RNA response to antiretroviral therapy | 1-gen-1999 | Romano, Laura; Venturi, G; Catucci, M; DE MILITO, A; Valensin, PIER EGISTO; Zazzi, Maurizio | - | |
| Evaluation of the presence of 2-LTR HIV-1 unintegrated DNA as a simple molecular predictor of disease progression. | 1-gen-1997 | Zazzi, Maurizio; Romano, Laura; Catucci, M.; Venturi, G.; DE MILITO, A.; Almi, P.; Gonnelli, A.; Rubino, M.; Occhini, U.; Valensin, PIER EGISTO | - |